859 related articles for article (PubMed ID: 16142737)
1. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
2. Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma.
Pijpe J; van Imhoff GW; Vissink A; van der Wal JE; Kluin PM; Spijkervet FK; Kallenberg CG; Bootsma H
Ann Rheum Dis; 2005 Jun; 64(6):958-60. PubMed ID: 15576414
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
Meijer JM; Meiners PM; Vissink A; Spijkervet FK; Abdulahad W; Kamminga N; Brouwer E; Kallenberg CG; Bootsma H
Arthritis Rheum; 2010 Apr; 62(4):960-8. PubMed ID: 20131246
[TBL] [Abstract][Full Text] [Related]
4. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.
Pollard RP; Pijpe J; Bootsma H; Spijkervet FK; Kluin PM; Roodenburg JL; Kallenberg CG; Vissink A; van Imhoff GW
J Rheumatol; 2011 Oct; 38(10):2198-208. PubMed ID: 21844152
[TBL] [Abstract][Full Text] [Related]
5. Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome.
Pijpe J; Meijer JM; Bootsma H; van der Wal JE; Spijkervet FK; Kallenberg CG; Vissink A; Ihrler S
Arthritis Rheum; 2009 Nov; 60(11):3251-6. PubMed ID: 19877054
[TBL] [Abstract][Full Text] [Related]
6. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
[TBL] [Abstract][Full Text] [Related]
8. [Combination of rituximab with combined pulse-therapy with high doses of methylprednisolone and cyclophosphamide: effects on immunomorphological and functional disturbances of the salivary glands in a patient with Sjogren's disease and MALT-lymphoma].
Vasil'ev VI; Kokosadze NV; Logvinenko OA; Nikitin EA; Mitrikov BV; Rodionova EB; Varlamova EIu
Ter Arkh; 2008; 80(5):76-9. PubMed ID: 18590121
[No Abstract] [Full Text] [Related]
9. Clinical course of primary Sjögren's syndrome: salivary, oral, and serologic aspects.
Gannot G; Lancaster HE; Fox PC
J Rheumatol; 2000 Aug; 27(8):1905-9. PubMed ID: 10955331
[TBL] [Abstract][Full Text] [Related]
10. [MALT-lymphomas in Sjogren's disease].
Vasil'ev VI; Probatova NA; Tupitsin NN; Varlamova EIu; Logvinenko OA; Rodionova EB; Kovrigina AM; Kokosadze NV; Panin MG; Gaĭduk IV; Gorbunova TV; Kondrat'eva TT; Sholokhova EN; Simonova MV; Safonova TN; Radenska-Lopovok SG
Ter Arkh; 2006; 78(1):45-52. PubMed ID: 16512445
[TBL] [Abstract][Full Text] [Related]
11. Lacrimal gland orbital lobe cysts associated with MALT lymphoma and primary Sjögren's syndrome.
Cassidy DT; McKelvie P; Harris GJ; Rose GE; McNab AA
Orbit; 2005 Dec; 24(4):257-63. PubMed ID: 16354635
[TBL] [Abstract][Full Text] [Related]
12. Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study.
Steinfeld SD; Tant L; Burmester GR; Teoh NK; Wegener WA; Goldenberg DM; Pradier O
Arthritis Res Ther; 2006; 8(4):R129. PubMed ID: 16859536
[TBL] [Abstract][Full Text] [Related]
13. Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.
Vissink A; Kalk WW; Mansour K; Spijkervet FK; Bootsma H; Roodenburg JL; Kallenberg CG; Nieuw Amerongen AV
Arch Otolaryngol Head Neck Surg; 2003 Sep; 129(9):966-71. PubMed ID: 12975269
[TBL] [Abstract][Full Text] [Related]
14. [The role of parotid gland biopsy in early detection of lymphoma in primary Sjogren's syndrome].
Vasil'iev VI; Logvinenko OA; Probatova NA; Kokosadze NV; Gorodetskiĭ VR; Kovrigina AM; Kondrat'eva TT; Mitrikov BV; Gaĭduk IV; Safonova TN; Simonova MV; Radenska-Lopovok SG; Varlamova EIu
Ter Arkh; 2009; 81(6):20-7. PubMed ID: 19663187
[TBL] [Abstract][Full Text] [Related]
15. [Rituximab therapy for systemic manifestations and MALT lymphomas of the parotid gland in Sjögren's disease: preliminary data].
Logvinenko OA; Vasil'ev VI; Sedyshev SKh; Safonova TN; Rodionova EB; Kokosadze NV; Aleksandrova EN; Cherkasova MV; Radenska-Lopovok SG; Nasonov EL
Ter Arkh; 2012; 84(12):88-96. PubMed ID: 23479998
[TBL] [Abstract][Full Text] [Related]
16. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
[TBL] [Abstract][Full Text] [Related]
17. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
[TBL] [Abstract][Full Text] [Related]
18. Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.
De Vita S; Quartuccio L; Salvin S; Picco L; Scott CA; Rupolo M; Fabris M
Clin Exp Rheumatol; 2014; 32(4):490-4. PubMed ID: 24802131
[TBL] [Abstract][Full Text] [Related]
19. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.
Pers JO; Devauchelle V; Daridon C; Bendaoud B; Le Berre R; Bordron A; Hutin P; Renaudineau Y; Dueymes M; Loisel S; Berthou C; Saraux A; Youinou P
Arthritis Rheum; 2007 May; 56(5):1464-77. PubMed ID: 17469105
[TBL] [Abstract][Full Text] [Related]
20. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
Mariette X; Ravaud P; Steinfeld S; Baron G; Goetz J; Hachulla E; Combe B; Puéchal X; Pennec Y; Sauvezie B; Perdriger A; Hayem G; Janin A; Sibilia J
Arthritis Rheum; 2004 Apr; 50(4):1270-6. PubMed ID: 15077311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
